News
2d
Medpage Today on MSNIBD Linked to Higher Risk of Lung DiseasePatients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...
Abatacept is linked to lower mortality and fewer hospitalizations than rituximab in patients with rheumatoid ...
Persistent cough that lasts beyond two weeks should not be ignored. It can be signs of chronic bronchitis, tuberculosis, ...
Detailed price information for Tectonic Therapeutic Inc (TECX-Q) from The Globe and Mail including charting and trades.
The FDA approved Hernexeos for adults with unresectable or metastatic non-squamous non-small cell lung cancer.
Despite him and his wife's doubts, Blood gave GoFundMe a shot, creating a TikTok video inside the Mayo Clinic. It starred him and their kids sharing facts about the clinic and its history of ...
Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...
From alveolar injury to extracellular matrix accumulation, the complex biology of pulmonary fibrosis is being unraveled ...
Anti-Ro52 seropositivity is linked to increased rates of ILD progression and a decrease in progression-free and transplant-free survival.
A new AI tool helps predict survival in fibrotic lung disease, outperforming traditional clinical and imaging methods in a study of over 1,200 patients.
Last patient visit completed in Phase 3 EFZO-FITâ„¢ study of efzofitimod in pulmonary sarcoidosis; topline results expected in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results